Clinical Trial Update: 26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation [Phase 3]

View source ↗

Summary

A Phase 3 efficacy and safety trial for chronic idiopathic constipation sponsored by Ferring was terminated, and results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Constipation

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Chronic Idiopathic Constipation | Phase 3 | Status: TERMINATED | Results posted: 2015-10-20